Blog

First-Time Developments Without the First-Time Risk: Protecting Your Asset’s Valuation 

In the high-stakes world of small-molecule development, the transition from pre-clinical “garage-style” synthesis to a scalable, GMP-ready clinical candidate is where most asset valuations either soar or plummet. For small and mid-sized pharma companies, this is not just a technical hurdle, it is a […]

Engineering a Foundation of Trust: The Kawagoe Approach to Security and Compliance

In the highly regulated world of pharmaceutical manufacturing, the production of controlled substances represents a pinnacle of complexity. The process demands that requirements for quality, safety, operability, regulatory compliance, and security are all satisfied simultaneously. This unyielding standard necessitates an […]

Subscribe to our newsletter!

Get notified on our latest news.